Skip to content
★ Sign in to follow
SV

Softbank Vision Fund (AIV M1) L.P.

Related company / holding
Total declarations
3
Company
1
▲ Purchases (2 ops.)
€35.5M
▼ Sales (0 ops.)
—

Latest filing published 15 Mar 2019 for Guardant Health, Inc., €17.8M.

Filing timeline

BuySale
Softbank Vision Fund (AIV M1) L.P.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-6.7%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 15 Mar 2019 · 2796 days ago · €17.8M
    -36.9%
    Entry US$93.50 · Close at T+365 US$59.04
  • Filed 14 Mar 2019 · 2797 days ago · €17.8M
    -39.7%
    Entry US$97.98 · Close at T+365 US$59.04

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Softbank Vision Fund (AIV M1) L.P.: trading record in brief

Softbank Vision Fund (AIV M1) L.P. appears in our data through filings on Guardant Health, Inc. shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 9 October 2018 to 12 March 2019.

The open-market record is one-sided, with 2 purchases worth €35.5M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2019: 2 purchases and no sales on the market.

The newest entry dates from 15 March 2019: an open-market purchase of €17.8M, in Guardant Health, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Softbank Vision Fund (AIV M1) L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total

3 of 3 declarations